Literature DB >> 12420098

Posterior reversible encephalopathy syndrome due to severe hypercalcemia.

O Kastrup1, M Maschke, I Wanke, H C Diener.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a leukoencephalopathy clinically characterized by headache, altered mental status, visual loss and seizures. Neuroimaging demonstrates symmetrical posterior cortical and subcortical lesions. The exact pathophysiology is unknown but there is a strong association with immunosuppressants and hypertension. We report two cases of PRES in normotensive patients with severe hypercalcemia as the only identifiable cause. Possible pathophysiological mechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12420098     DOI: 10.1007/s00415-002-0895-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  27 in total

1.  [Acute bilateral loss of vision in posterior reversible encephalopathy syndrome].

Authors:  K S Bonsel; I Oberacher-Velten; K Hufendiek; H Jägle
Journal:  Ophthalmologe       Date:  2013-03       Impact factor: 1.059

Review 2.  Posterior reversible encephalopathy syndrome in intensive care medicine.

Authors:  Giuseppe Servillo; Francesca Bifulco; Edoardo De Robertis; Ornella Piazza; Pasquale Striano; Fabio Tortora; Salvatore Striano; Rosalba Tufano
Journal:  Intensive Care Med       Date:  2006-11-21       Impact factor: 17.440

3.  TNF-antagonist etanercept induced reversible posterior leukoencephalopathy syndrome.

Authors:  Oliver Kastrup; Hans Christoph Diener
Journal:  J Neurol       Date:  2008-02-20       Impact factor: 4.849

Review 4.  Electroencephalography of encephalopathy in patients with endocrine and metabolic disorders.

Authors:  Roland Faigle; Raoul Sutter; Peter W Kaplan
Journal:  J Clin Neurophysiol       Date:  2013-10       Impact factor: 2.177

5.  Hypertension-induced posterior reversible encephalopathy syndrome as the presentation of progressive bilateral renal artery stenosis.

Authors:  Aurelio Negro; Gianni De Berti; Massimo Maggi; Rosaria Santi; Chiara Grasselli; Ermanno Rossi
Journal:  J Cardiol Cases       Date:  2011-10-04

6.  Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging.

Authors:  Lauren M Brubaker; J Keith Smith; Yueh Z Lee; Weili Lin; Mauricio Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

7.  Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?

Authors:  Christina Mueller-Mang; Thomas Mang; Agnes Pirker; Katharina Klein; Christine Prchla; Daniela Prayer
Journal:  Neuroradiology       Date:  2009-02-21       Impact factor: 2.804

8.  Posterior Reversible Encephalopathy Syndrome: The Spectrum of MR Imaging Patterns.

Authors:  O Kastrup; M Schlamann; C Moenninghoff; M Forsting; S Goericke
Journal:  Clin Neuroradiol       Date:  2014-02-20       Impact factor: 3.649

9.  The role of tumor lysis in reversible posterior leukoencephalopathy syndrome.

Authors:  Emiko Kaito; Satoshi Terae; Ryoji Kobayashi; Kohsuke Kudo; Khin Khin Tha; Kazuo Miyasaka
Journal:  Pediatr Radiol       Date:  2005-03-09

10.  Reversible encephalopathy syndrome: report of 12 cases with follow-up.

Authors:  S Greco Crasto; L Rizzo; P Sardo; O Davini; R De Lucchi
Journal:  Neuroradiology       Date:  2004-10       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.